Common Stock (Tables)

12 Months Ended

Dec. 31, 2023

Equity [Abstract]

Schedule of Common Stock Reserved for Future Issuance

As of December 31, 2023 and 2022, the Company’s Common Stock reserved for future issuance was as follows:

	As of December 31,
	2023	2022
Shares available for future grants under Equity Incentive Plan	3,526,392	1,570,353
Outstanding stock options	9,630,623	5,036,946
Performance-based restricted stock units	2,964,072	—
Outstanding restricted stock units	2,166,016	1,107,213
Options assumed upon ValenzaBio acquisition	938,440	—
ESPP Shares available for future grants	875,836	—
Redeemable convertible preferred stock	—	40,743,522
Total shares reserved for future issuance	20,101,379	48,458,034